Genenta Science SpA ADR
SAENIndustrials·Conglomerates·Italy·Nano·NASD·Nov 11 • 3:59 PM ET
0.6800-0.0379 (-5.28%)
2026-11-12 09:04 CET
Market cap
32.79 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-7.33 USD m
Free cash flow, TTM
-8.02 USD m
EPS diluted, TTM
-0.37
P/E
-
Price
SAEN against its 20, 50 and 200-day averages2050200earnings
Patternshover a marker to name it
EPS mean, own scalevs SPY
73.6% under the 52-week high of 2.58 on 2 Jun 2026. 52-week low 0.55 on 14 May 2026. Last 15 sessions, 78.4% high to low
Volume 0.10× normal · the line is the 50-bar volume average
Profile
SAEN52-week range, 6% of the way up
0.552.58
Genenta Science SpA operates as a biotechnology company, which engages in strategic consolidation focused on acquiring majority or full ownership of privately held, established companies operating in Italian national security-regulated sectors. Its activities and acquisition strategy span aerospace, defense, national security, including cybersecurity, and biotechnology and biosecurity. The company was founded by Pierluigi Paracchi, Bernhard Gentner, and Luigi Naldini on July 24, 2014 and is headquartered in Milan, Italy.
| Employees | 9 |
|---|---|
| IPO | Dec 15, 2021 |
| Beta | 0.74 |
| ATR, 14d | 0.10 |
| Rel volume | 0.10 |
| Inst own | 2.98% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | 32.79M |
| Enterprise Value | 8.66M |
| Income | -7.33M |
| Sales | 0.00M |
| Book/sh | 1.09 |
| Cash/sh | 0.69 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 9 |
| IPO | Dec 15, 2021 |
Ratios
| P/E | - |
|---|---|
| Forward P/E | - |
| PEG | - |
| P/S | - |
| P/B | 0.62 |
| P/C | 0.99 |
| P/FCF | - |
| EV/EBITDA | - |
| EV/Sales | - |
| Quick Ratio | 14.16 |
| Current Ratio | 14.16 |
| Debt/Eq | 0.35 |
| LT Debt/Eq | 0.35 |
| Option/Short | No / Yes |
Earnings
| EPS (ttm) | -0.37 |
|---|---|
| EPS next Y | - |
| EPS next Q | - |
| EPS this Y | - |
| EPS next Y | - |
| EPS next 5Y | - |
| EPS past 3/5Y | 8.56% -1.23% |
| Sales past 3/5Y | - - |
| EPS Y/Y TTM | 29.62% |
| Sales Y/Y TTM | - |
| EPS Q/Q | 48.49% |
| Sales Q/Q | - |
| Earnings | Jul 22 BMO |
| EPS/Sales Surpr. | - - |
Ownership
| Insider Own | - |
|---|---|
| Insider Trans | - |
| Inst Own | 2.98% |
| Inst Trans | -15.83% |
| ROA | -27.77% |
| ROE | -38.00% |
| ROIC | -21.20% |
| Gross Margin | - |
| Oper. Margin | - |
| Profit Margin | - |
| SMA20 | 0.75% |
| SMA50 | -7.48% |
| SMA200 | -32.89% |
| Trades | - |
Technical
| Shs Outstand | 23.43M |
|---|---|
| Shs Float | - |
| Short Float | - |
| Short Ratio | 0.96 |
| Short Interest | 0.08M |
| 52W High | 2.58 -73.64% |
| 52W Low | 0.55 23.64% |
| Volatility | 15.14% 11.85% |
| ATR (14) | 0.10 |
| RSI (14) | 47.74 |
| Beta | 0.74 |
| Rel Volume | 0.10 |
| Avg Volume | 85.20K |
| Volume | 8,489 |
Performance
| Perf Week | -2.86% |
|---|---|
| Perf Month | -5.82% |
| Perf Quarter | -47.69% |
| Perf Half Y | 15.88% |
| Perf YTD | -54.36% |
| Perf Year | -69.09% |
| Perf 3Y | -87.44% |
| Perf 5Y | - |
| Perf 10Y | - |
| Recom | 1.00 |
| Target Price | 6.94 |
| Prev Close | 0.72 |
| Price | 0.68 |
| Change % | -5.28% |
Analyst ratings
latest 3 of 3| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Jun 29, 2023 | Resumed | RROTH MKM | Buy | $15 | +2,105.9% |
| Jul 25, 2022 | Initiated | HH.C. Wainwright | Buy | $25 | +3,576.5% |
| Jan 13, 2022 | Initiated | MMaxim Group | Buy | $21 | +2,988.2% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| SPAI | Safe Pro Group Inc | 63.78M |
| BYRN | Byrna Technologies Inc | 97.60M |
| MOB | Mobilicom Limited | 29.85M |
| XTIA | XTI Aerospace Inc | 37.71M |
| AIRI | Air Industries Group | 13.39M |
| PUSA | Powerus Corp | 224.56M |
| DPRO | Draganfly Inc | 117.42M |
| KITT | Nauticus Robotics Inc | 2.07M |
| HLSQ | Tessera Defense and Homeland Security Inc | 1.86M |
| ONDS | Ondas Inc | 3.34B |
News
latest 14 of 68- Genenta Unveils Saentra Forge as Its New Brand, Advancing Its Transformation into a Strategic Industrial Platform (GlobeNewswire) +32.07%
- Genenta Science Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification (GlobeNewswire)
- Sophia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit (GlobeNewswire)
- Genenta-backed Sophia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm (GlobeNewswire)
- Genenta-Backed Sophia High Tech Reports Fiscal Year 2025 Results (GlobeNewswire)
- Genenta signs Definitive Agreements with Sophia High Tech (GlobeNewswire)
- Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sophia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs (GlobeNewswire) -14.29%
- Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini (GlobeNewswire) +8.19%
- Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University (GlobeNewswire)
- Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business (Insider Monkey)
- Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform (GlobeNewswire)
- Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments (Benzinga) +18.46%
- Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator (GlobeNewswire)
- Genenta Science Provides Update on CEO Ownership (GlobeNewswire)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026S1 | 2026-07-22 | - | -0.279 | - | - | - | 1 |
| 2025S2 | 2026-02-25 | -0.360 | -0.364 | -0.149 | 0.00 | - | 1 |
| 2025S1 | 2025-09-03 | -0.424 | - | -0.223 | 0.00 | - | - |
| 2024S2 | 2025-02-26 | -0.292 | -0.257 | -0.289 | 0.00 | 0.00 | 1 |
| 2024S1 | 2024-08-28 | -0.307 | - | -0.239 | 0.00 | - | - |
| 2023S2 | 2024-02-28 | -0.293 | -0.410 | -0.290 | 5.37 | - | 1 |
| 2022S2 | 2023-04-26 | -0.372 | -0.385 | -0.412 | 0.00 | 0.00 | 2 |
| 2022S1 | 2022-10-24 | -0.127 | - | -0.118 | 0.00 | - | 1 |
| 2021S2 | 2022-06-10 | -0.107 | - | -0.107 | - | - | 1 |
| 2026S2 | - | - | -0.255 | - | - | - | 1 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2021FY | -0.399 | -0.635 | -0.359 | 0.00 | 0.00 |
| 2022FY | -0.515 | - | -0.489 | 0.00 | - |
| 2023FY | -0.554 | -0.679 | -0.813 | 5.42 | 5.38 |
| 2024FY | -0.530 | -0.494 | -0.528 | 0.00 | 0.00 |
| 2025FY | -0.604 | -0.610 | -0.374 | 5.74 | - |
| 2026FY | - | -0.534 | - | - | - |
| 2027FY | - | -0.615 | - | - | - |
| 2028FY | - | -0.221 | - | - | 41.56 |
| 2029FY | - | 0.824 | - | - | 121.02 |
| 2030FY | - | 2.032 | - | - | 196.72 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026S1 | R | 2026-03-04 | 1 | 0 | 0 | -0.28 | -0.28 | -0.28 |
| 2026S1 | R | 2026-02-25 | 1 | 1 | 0 | -0.28 | -0.28 | -0.28 |
| 2026S1 | R | 2025-12-19 | 1 | 1 | 0 | -0.28 | -0.28 | -0.28 |
| 2026S1 | R | 2025-09-09 | 1 | 0 | 0 | -0.45 | -0.45 | -0.45 |
| 2026S1 | E | 2026-03-04 | 1 | 0 | 0 | -0.28 | -0.28 | -0.28 |
| 2026S1 | E | 2026-02-25 | 1 | 1 | 0 | -0.28 | -0.28 | -0.28 |
| 2026S1 | E | 2025-12-19 | 1 | 1 | 0 | -0.28 | -0.28 | -0.28 |
| 2026S1 | E | 2025-09-09 | 1 | 0 | 0 | -0.45 | -0.45 | -0.45 |
| 2026FY | R | 2026-03-04 | 1 | 0 | 0 | -0.53 | -0.53 | -0.53 |
| 2026FY | R | 2026-02-25 | 1 | 1 | 0 | -0.54 | -0.54 | -0.54 |
| 2026FY | R | 2025-12-19 | 1 | 1 | 0 | -0.54 | -0.54 | -0.54 |
| 2026FY | R | 2025-09-09 | 1 | 0 | 0 | -0.85 | -0.85 | -0.85 |
| 2026FY | E | 2026-03-04 | 1 | 0 | 0 | -0.53 | -0.53 | -0.53 |
| 2026FY | E | 2026-02-25 | 1 | 1 | 0 | -0.54 | -0.54 | -0.54 |
Estimate history
| EPS, annual | -0.284 | -0.352 | -0.359 | -0.489 | -0.691 | -0.528 | -0.374 |
|---|---|---|---|---|---|---|---|
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| EPS, quarterly | |||||||
| Period | |||||||
| Sales, annual | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Sales, quarterly | |||||||
| Period | |||||||
| Shares, annual | 18.12 | 18.12 | 18.217 | 18.217 | 18.217 | 18.29 | 23.432 |
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Shares, quarterly | |||||||
| Period |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.03 | 0.03 | 0.05 | 0.05 | 0.01 | 0.01 | 0.00 | 0.00 |
| Gross Profit | -0.03 | -0.03 | -0.05 | -0.05 | -0.01 | -0.01 | -0.00 | 0.00 |
| Selling, General and Administrative Excl. Other | 7.42 | 7.42 | 10.51 | 12.64 | 11.60 | 6.72 | 6.37 | 5.18 |
| Research and Development | 3.04 | 3.05 | 5.21 | 7.00 | 5.61 | 4.01 | 5.34 | 4.14 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -7.45 | -7.45 | -10.56 | -12.68 | -11.61 | -6.72 | -6.37 | -5.18 |
| Interest Expense | 0.44 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -7.33 | -7.37 | -9.64 | -12.59 | -8.91 | -6.54 | -6.37 | -5.15 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -7.33 | -7.37 | -9.64 | -12.59 | -8.91 | -6.54 | -6.37 | -5.15 |
| Net Income From Continuing Operations | -7.33 | -7.37 | -9.64 | -12.59 | -8.91 | -6.54 | -6.37 | -5.15 |
| Net Income | -7.33 | -7.37 | -9.64 | -12.59 | -8.91 | -6.54 | -6.37 | -5.15 |
| EPS (Recurring) | -0.35 | -0.37 | -0.53 | -0.69 | -0.49 | -0.36 | -0.35 | -0.28 |
| EPS (Basic, Before Extraordinaries) | -0.37 | -0.37 | -0.53 | -0.69 | -0.49 | -0.36 | -0.35 | -0.28 |
| EPS (Diluted) | -0.37 | -0.37 | -0.53 | -0.69 | -0.49 | -0.36 | -0.35 | -0.28 |
| EBITDA | -7.42 | -7.42 | -10.51 | -12.64 | -11.60 | -6.72 | -6.37 | -5.18 |
| Non-Operating Income (Expense) | 0.56 | 0.53 | 0.92 | 0.09 | 2.70 | 0.19 | -0.00 | 0.03 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 1.07 | 1.06 | 0.92 | 0.80 | 0.76 | 0.59 | 0.52 | 0.83 |
| Shares Outstanding | 23.43 | 23.43 | 18.29 | 18.22 | 18.22 | 18.22 | 18.12 | 18.12 |
| Market Capitalization | 32.79 | 32.79 | 79.56 | 90.17 | 100.19 | 198.63 | 201.53 | - |
Income statement, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 | 2023S2 | 2023S1 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Gross Profit | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Selling, General and Administrative Excl. Other | 3.74 | 3.68 | 5.65 | 4.86 | 5.31 | 7.33 |
| Research and Development | 1.45 | 1.59 | 3.00 | 2.21 | 2.76 | 4.24 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -3.76 | -3.69 | -5.68 | -4.88 | -5.34 | -7.35 |
| Interest Expense | 0.01 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -3.15 | -4.18 | -5.28 | -4.37 | -5.29 | -7.30 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -3.15 | -4.18 | -5.28 | -4.37 | -5.29 | -7.30 |
| Net Income From Continuing Operations | -3.15 | -4.18 | -5.28 | -4.37 | -5.29 | -7.30 |
| Net Income | -3.15 | -4.18 | -5.28 | -4.37 | -5.29 | -7.30 |
| EPS (Recurring) | -0.15 | -0.22 | -0.29 | -0.24 | -0.29 | -0.40 |
| EPS (Basic, Before Extraordinaries) | -0.15 | -0.22 | -0.29 | -0.24 | -0.29 | -0.40 |
| EPS (Diluted) | -0.15 | -0.22 | -0.29 | -0.24 | -0.29 | -0.40 |
| EBITDA | -3.74 | -3.68 | -5.65 | -4.86 | -5.31 | -7.33 |
| Non-Operating Income (Expense) | 0.61 | -0.06 | 0.40 | 0.52 | 0.05 | 0.04 |
| Stock Option Compensation Expense | 0.68 | 0.38 | 0.67 | 0.25 | 0.35 | 0.45 |
| Shares Outstanding | 23.43 | 19.15 | 18.29 | 18.29 | 18.22 | 18.22 |
| Market Capitalization | 32.79 | 55.69 | 79.56 | 56.47 | 90.17 | 107.37 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY |
|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 33.06 | 13.11 | 20.74 | 31.80 | 42.35 | 18.92 | 22.61 |
| Short Term Receivables | 0.70 | 0.78 | 0.92 | 0.69 | 0.68 | 0.34 | 0.22 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 1.44 | 1.10 | 1.82 | 1.36 | 1.05 | 0.77 | 0.30 |
| Total Current Assets | 35.21 | 14.99 | 23.48 | 33.85 | 44.08 | 20.04 | 23.12 |
| Net Property, Plant & Equipment | 0.03 | 0.04 | 0.09 | 0.12 | 0.03 | 0.02 | 0.00 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Note Receivable | 2.21 | 0.30 | 0.88 | - | - | - | - |
| Other Assets | 0.01 | 0.02 | 0.23 | 1.71 | 1.42 | 1.35 | 0.84 |
| Total Assets | 37.45 | 15.35 | 24.69 | 35.69 | 45.52 | 21.41 | 23.96 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 2.49 | 2.17 | 1.92 | 2.33 | 1.29 | 2.86 | 2.79 |
| Total Current Liabilities | 2.49 | 2.17 | 1.92 | 2.33 | 1.29 | 2.86 | 2.79 |
| Long Term Debt | 8.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.38 | 0.24 | 0.18 | 0.09 | 0.03 | 0.02 | 0.01 |
| Other Liabilities | 0.00 | 0.00 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 11.80 | 2.41 | 2.12 | 2.45 | 1.33 | 2.88 | 2.80 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 25.65 | 12.94 | 22.57 | 33.23 | 44.19 | 18.54 | 21.16 |
| Total Shareholders Equity | 25.65 | 12.94 | 22.57 | 33.23 | 44.19 | 18.54 | 21.16 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 25.65 | 12.94 | 22.57 | 33.23 | 44.19 | 18.54 | 21.16 |
| Total Liabilities & Stockholders Equity | 37.45 | 15.35 | 24.69 | 35.69 | 45.52 | 21.41 | 23.96 |
| Book Value Per Share | 1.09 | 0.71 | 1.24 | 1.82 | 2.43 | 1.02 | 1.17 |
| Tangible Book Value Per Share | 1.09 | 0.71 | 1.24 | 1.82 | 2.43 | 1.02 | 1.17 |
| Full-Time Employees | 9 | 13 | 14 | 9 | 7 | 4 | - |
| Price to Book Ratio | 0.62 | 4.41 | 3.33 | - | - | - | - |
| Return on Assets | -27.91 | -48.16 | -41.71 | -21.94 | -19.53 | -28.10 | - |
| Return on Equity | -38.19 | -54.30 | -45.12 | -23.02 | -20.84 | -32.12 | - |
| Return on Invested Capital | -21.31 | -74.51 | -55.78 | -26.81 | -14.79 | -34.39 | -24.32 |
| Quick Ratio | 14.16 | 6.89 | 12.25 | 14.53 | 34.15 | 7.02 | 8.29 |
| Current Ratio | 14.16 | 6.89 | 12.25 | 14.53 | 34.15 | 7.02 | 8.29 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY |
|---|---|---|---|---|---|---|---|---|
| Net Income | -7.62 | -7.37 | -9.64 | -12.59 | -8.91 | -6.54 | -6.37 | -5.15 |
| Depreciation | 0.03 | 0.03 | 0.05 | 0.05 | 0.01 | 0.01 | 0.00 | 0.00 |
| Other Funds (Non Cash) | 1.41 | 1.37 | 0.98 | 0.88 | 0.85 | 0.60 | 0.53 | 0.84 |
| Funds from Operations | -6.17 | -5.97 | -8.61 | -11.66 | -8.05 | -5.93 | -5.84 | -4.30 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -1.84 | -1.78 | 1.86 | -0.45 | 0.25 | -2.30 | -1.05 | 1.51 |
| Cash from Operating Activities | -8.01 | -7.75 | -6.75 | -12.11 | -7.80 | -8.22 | -6.89 | -2.79 |
| Capital Expenditures | -0.01 | -0.01 | -0.00 | -0.01 | -0.03 | -0.01 | -0.02 | 0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -16.95 | -16.41 | 7.45 | -16.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | -38.68 | -37.43 | -17.72 | -16.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 21.73 | 21.02 | 25.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -16.96 | -16.41 | 7.45 | -16.10 | -0.03 | -0.01 | -0.02 | 0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.63 | 16.53 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.63 | 16.53 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 8.75 | 8.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 8.75 | 8.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 8.75 | 8.46 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 17.25 | 16.69 | 0.29 | 0.00 | 0.00 | 33.97 | -0.05 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.05 | 0.00 |
| Cash from Financing Activities | 25.99 | 25.15 | 0.29 | 0.00 | 0.00 | 33.97 | 1.58 | 16.53 |
| Exchange Rate Effect | 0.08 | 0.08 | -0.03 | -0.01 | - | - | - | - |
| Net Change in Cash | 1.10 | 1.07 | 0.96 | -28.22 | -7.82 | 25.74 | -5.33 | 13.74 |
| Free Cash Flow | -8.02 | -7.76 | -6.75 | -12.13 | -7.82 | -8.24 | -6.91 | -2.79 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 | 2023S2 | 2023S1 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 33.06 | 20.74 | 13.11 | 18.12 | 20.74 | 24.23 |
| Short Term Receivables | 0.70 | 1.07 | 0.78 | 0.82 | 0.92 | 2.11 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 1.44 | 2.84 | 1.10 | 0.96 | 1.82 | 0.40 |
| Total Current Assets | 35.21 | 24.65 | 14.99 | 19.90 | 23.48 | 26.75 |
| Net Property, Plant & Equipment | 0.03 | 0.04 | 0.04 | 0.07 | 0.09 | 0.11 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.01 | 0.01 | 0.02 | 0.03 | 0.23 | 0.24 |
| Total Assets | 37.45 | 25.30 | 15.35 | 20.38 | 24.69 | 29.16 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 2.49 | 1.87 | 2.17 | 2.14 | 1.92 | 1.93 |
| Total Current Liabilities | 2.49 | 1.87 | 2.17 | 2.14 | 1.92 | 1.93 |
| Long Term Debt | 8.93 | 8.87 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
| Total Liabilities | 11.80 | 11.08 | 2.41 | 2.36 | 2.12 | 2.10 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 25.65 | 14.22 | 12.94 | 18.02 | 22.57 | 27.06 |
| Total Shareholders Equity | 25.65 | 14.22 | 12.94 | 18.02 | 22.57 | 27.06 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 25.65 | 14.22 | 12.94 | 18.02 | 22.57 | 27.06 |
| Total Liabilities & Stockholders Equity | 37.45 | 25.30 | 15.35 | 20.38 | 24.69 | 29.16 |
| Book Value Per Share | 1.09 | 0.74 | 0.71 | 0.99 | 1.24 | 1.49 |
| Tangible Book Value Per Share | 1.09 | 0.74 | 0.71 | 0.99 | 1.24 | 1.49 |
| Price to Book Ratio | 0.62 | 4.30 | 4.41 | 2.50 | 3.33 | 3.97 |
| Return on Assets | -27.77 | -41.40 | -48.16 | -38.96 | - | - |
| Return on Equity | -38.00 | -58.65 | -54.30 | -42.81 | - | - |
| Return on Invested Capital | -9.12 | -18.10 | -40.78 | -24.22 | -23.42 | -26.99 |
| Quick Ratio | 14.16 | 13.20 | 6.89 | 9.30 | 12.25 | 13.84 |
| Current Ratio | 14.16 | 13.20 | 6.89 | 9.30 | 12.25 | 13.84 |
Cash flow, quarterly
| Metric | 2025S2 | 2025S1 | 2024S2 | 2024S1 | 2023S2 | 2023S1 |
|---|---|---|---|---|---|---|
| Net Income | -3.44 | -4.18 | -5.28 | -4.37 | -5.29 | -7.30 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Other Funds (Non Cash) | 0.83 | 0.58 | 0.70 | 0.29 | 0.39 | 0.49 |
| Funds from Operations | -2.59 | -3.58 | -4.56 | -4.06 | -4.88 | -6.79 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.60 | -2.44 | 0.03 | 1.83 | 0.95 | -1.40 |
| Cash from Operating Activities | -1.99 | -6.02 | -4.53 | -2.22 | -3.93 | -8.19 |
| Capital Expenditures | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -12.12 | -4.84 | 2.81 | 4.65 | -5.30 | -10.79 |
| Purchase of Investments | -25.11 | -13.57 | -8.01 | -9.73 | -5.30 | -10.79 |
| Sale Or Maturity of Investments | 13.00 | 8.73 | 10.81 | 14.38 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -12.12 | -4.85 | 2.80 | 4.65 | -5.30 | -10.81 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 0.00 | -0.29 | 0.29 | 0.00 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00 | -0.29 | 0.29 | 0.00 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | -0.29 | 0.29 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.56 | 8.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.56 | 8.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.56 | 8.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 13.99 | 3.25 | 0.29 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 14.55 | 11.44 | 0.00 | 0.29 | 0.00 | 0.00 |
| Exchange Rate Effect | 0.01 | 0.08 | -0.01 | -0.02 | - | - |
| Net Change in Cash | 0.45 | 0.65 | -1.73 | 2.70 | -9.24 | -19.00 |
| Free Cash Flow | -1.99 | -6.03 | -4.53 | -2.23 | -3.93 | -8.20 |
Revenue breakdown
| Revenue split | - |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | - | 0.1M | - | 53.38K |
| 2026-10-15 | - | 0.1M | - | 57.64K |
| 2026-09-30 | - | 0.1M | - | 65.26K |
| 2026-09-15 | - | 0.1M | - | 108.22K |
| 2026-08-31 | - | 0.1M | - | 1.28M |
| 2026-08-14 | - | 0.1M | - | 1.46M |
| 2026-07-31 | - | 0.1M | - | 1.46M |
| 2026-07-15 | - | 0.1M | - | 1.48M |
| 2026-06-30 | - | 0.2M | - | 1.45M |
| 2026-06-15 | - | 0.2M | - | 1.40M |
| 2026-05-29 | - | 0.3M | - | 226.89K |
| 2026-05-15 | - | 0.0M | - | 74.97K |
| 2026-04-30 | - | 0.0M | - | 96.03K |
| 2026-04-15 | - | 0.1M | - | 1.07M |
| 2026-03-31 | - | 0.1M | - | 1.07M |
| 2026-03-13 | - | 0.0M | - | 1.06M |
| 2026-02-27 | - | 0.1M | - | 1.05M |
| 2026-02-13 | - | 0.1M | - | 1.06M |
| 2026-01-30 | - | 0.2M | - | 1.06M |
| 2026-01-15 | - | 0.1M | - | 698.31K |
Option chain
expiry 2026-11-12| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-02 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-11-02 | SEC |
| 2026-10-22 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-22 | SEC |
| 2026-10-21 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-21 | SEC |
| 2026-10-13 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-13 | SEC |
| 2026-10-07 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-10-07 | SEC |
| 2026-10-02 | SCHEDULE 13D/A | SEC | ||
| 2026-09-11 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-11 | SEC |
| 2026-09-02 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-09-01 | SEC |
| 2026-07-31 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-07-31 | SEC |
| 2026-07-14 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-07-14 | SEC |
| 2026-07-01 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-07-01 | SEC |
| 2026-06-26 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-26 | SEC |
| 2026-06-24 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-24 | SEC |
| 2026-06-17 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-17 | SEC |
| 2026-06-16 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-06-16 | SEC |
| 2026-05-29 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-05-29 | SEC |
| 2026-05-19 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-05-19 | SEC |
| 2026-05-05 | SCHEDULE 13D | SEC | ||
| 2026-05-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-30 | SEC |
| 2026-04-28 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-04-28 | SEC |
| 2026-04-23 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-04-23 | SEC |
| 2026-04-14 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-04-14 | SEC |
| 2026-04-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-30 | SEC |
| 2026-04-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-30 | SEC |
| 2026-04-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-30 | SEC |
| 2026-04-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-30 | SEC |
| 2026-04-01 | 20-F | Registration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer. | 2025-12-31 | SEC |
| 2026-03-27 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-03-27 | SEC |
| 2026-03-25 | 3 | Initial statement of beneficial ownership of securities | 2026-03-18 | SEC |
| 2026-03-24 | 6-K | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 | 2026-03-23 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| ALLIANZ SE | 1.00% |
| Eurizon Capital SGR S.p.A. | 0.75% |
| AlTi Global, Inc. | 0.42% |
| SmartHarvest Portfolios, LLC | 0.19% |
| Virtu Financial LLC | 0.16% |
| Ground Swell Capital, LLC | 0.06% |
| Simplicity Wealth,LLC | 0.04% |
| Financial Planning Navigators CORP | 0.02% |
| GAMMA Investing LLC | 0.01% |
| UBS Group AG | 0.01% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Nasdaq Composite Index Fund | 0.03% |
OakChart. SAEN. Cached 15 minutes.
Some panels did not load: insider.